Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sinopep-Allsino Biopharmaceutical Co. Ltd. A

688076
Current price
54.22 CNY -0.78 CNY (-1.42%)
Last closed 55.28 CNY
ISIN CNE1000051X5
Sector Healthcare
Industry Biotechnology
Exchange Shanghai Stock Exchange
Capitalization 11 585 436 705 CNY
Yield for 12 month +29.22 %
1Y
3Y
5Y
10Y
15Y
688076
21.11.2021 - 28.11.2021

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers formulations, such as thymalfasin products for injection, eptifibatide injections, alogliptin benzoate tablets, and oseltamivir phosphate capsules; APIs and intermediates; and drugs for type 2 diabetes and obesity, and coronavirus. It also provides pharmaceutical research, clinical, and registration services of drugs; and undertakes CDMO/CMO projects of small molecule chemical API and intermediates. The company was founded in 2009 and is headquartered in Hangzhou, China. Address: Building E, Hangzhou, China, 311121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

636.46 CNY

P/E ratio

27.5183

Dividend Yield

0.93 %

Current Year

+1 036 572 163 CNY

Last Year

+653 197 336 CNY

Current Quarter

+477 075 423 CNY

Last Quarter

+356 856 222 CNY

Current Year

+631 996 484 CNY

Last Year

+376 067 225 CNY

Current Quarter

+321 336 308 CNY

Last Quarter

+240 036 795 CNY

Key Figures 688076

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 628 869 151 CNY
Operating Margin TTM 38.61 %
PE Ratio 27.5183
Return On Assets TTM 8.01 %
PEG Ratio
Return On Equity TTM 18.42 %
Wall Street Target Price 636.46 CNY
Revenue TTM 1 580 946 697 CNY
Book Value 11.94 CNY
Revenue Per Share TTM
Dividend Share 0.5 CNY
Quarterly Revenue Growth YOY 36.3 %
Dividend Yield 0.93 %
Gross Profit TTM 344 360 352 CNY
Earnings per share 1.92 CNY
Diluted Eps TTM 1.92 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 148.4 %
Profit Margin 26.74 %

Dividend Analytics 688076

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

25 %

Dividend History 688076

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.5
Ex Dividend Date 10.09.2024
Forward Annual Dividend Yield 0.95 %
Last Split Factor
Payout Ratio 26.18 %
Last Split Date
Dividend Date

Stock Valuation 688076

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 27.5183
Forward PE
Enterprise Value Revenue 7.7554
Price Sales TTM 7.6349
Enterprise Value EBITDA 25.9207
Price Book MRQ 4.4146

Financials 688076

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688076

For 52 weeks

35.44 CNY 81.74 CNY
50 Day MA 57.64 CNY
Shares Short Prior Month
200 Day MA 57.4 CNY
Short Ratio
Shares Short
Short Percent